LUNGevity’s Dr. Upal Basu Roy and Dr. Amy Moore will be live-tweeting from the American Society of Clinical Oncology (ASCO) annual meeting. Follow LUNGevity on Twitter and the hashtags #ASCO22 and #LCSM to be a part of the action. Times and topics of live-tweeted sessions are as follows:
In 2021, LUNGevity Foundation announced our inaugural Health Equity and Inclusiveness Workforce Development Awards to help combat the lack of diversity among lung cancer researchers as well as disparities in the lung cancer research itself. To learn more about the health disparities research and why it matters to all people, LUNGevity Foundation spoke with Robert Winn, MD, director of the Virginia Commonwealth University Massey Cancer Center and member of LUNGevity’s Board of Directors.
Living with cancer means processing difficult emotions as well as dealing with side effects and physical changes both during treatment and beyond. Living with lung cancer brings an additional challenge of its own.
Lung cancer continues to be the number-one cause of cancer deaths in the United States. In the past decade, we have seen great improvements in the treatment of metastatic lung cancer with targeted therapies and immunotherapy.
The lung cancer community has a unique and urgent opportunity to influence the future of lung cancer research funding in Congress. The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Program (CDMRP) within the Department of Defense, is an important source of federal funding for lung cancer research.
It can be difficult to decide what information to disclose at your workplace when navigating a cancer diagnosis. You may question whether or not to share your diagnosis with coworkers, what information you’ll be required to tell your employer, and how to receive workplace benefits such as time off or reasonable accommodations for your condition.
